Catalyst Wire Dossier Catalyst Wire Dossier

Epoetin Beta (Recormon)

epoetin beta · Hoffmann-La Roche
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Epoetin Beta (Recormon), covering 2017-07-02 to 2017-07-02. Get the full timeline:

Most recent: Clinical Trial Update: A Study of the Quality of Life and Treatment Response to Once Weekly Epoetin Beta (Recormon) Treatment in Anemic Participants With Solid and Lymphoid Malignancies [Phase 4]

See pricing